We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Rapid Blood Test Allows for Earlier Detection of Pregnancy

By LabMedica International staff writers
Posted on 07 Sep 2015
Print article
Image: The AdexusDx hCG early pregnancy testing kit (Photo Courtesy of NOWDiagnostics).
Image: The AdexusDx hCG early pregnancy testing kit (Photo Courtesy of NOWDiagnostics).
Early detection of pregnancy is important for caregivers in order to avoid certain medications and procedures that could harm a fetus, but unfortunately, clinics are experiencing too many false-negative results from point-of-care urine-based tests.

An immunoassay used for the qualitative detection of human chorionic gonadotropin (hCG) in human whole blood, plasma or serum is now available and the test is used as an early detection aid for pregnancy for health care professionals in a variety of clinical and critical care settings.

The assay has now been Clinical Laboratory Improvement Amendments (CLIA) registered and classified by the US Food and Drug Administration (FDA; Silver Springs, MD, USA). The new hCG test is the first single-step, capillary blood hCG test requiring no equipment to receive FDA 510(k) clearance. The hCG test can detect pregnancy approximately two to eight days earlier than commonly available urine-based tests. The hCG test results are available 10 minutes after the test is used.

The ADEXUSDx hCG Test is a from a product line manufactured by NOWDiagnostics Inc. (Springdale, AR, USA). The patented technology allows physicians to easily and accurately receive results within minutes by using a single drop of capillary or whole blood. Testing is a single-step process that can identify common conditions, illnesses and diseases with the same or better accuracy, sensitivity, specificity and precision as a predicate device in a full-scale laboratory. The diagnostic test kits can be processed in as little as 5 to 15 minutes, onsite in-clinic and by staff technicians and nurses.

Kevin Clark, CEO and president and of NOWDiagnostics Inc., said, “It's too important for the safety of the mother and fetus to not have accurate pregnancy results in our emergency rooms and clinics. Our hCG test can save lives and reduce liability for health care providers. We see a great opportunity to save hospitals and clinics time, money and resources by providing them a lab in the palm of their hands.”

Related Links:

US Food and Drug Administration
NOWDiagnostics Inc. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.